Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) ...
LAS VEGAS, Dec. 10, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT) is thrilled to announce the launch of Xcellara™ Stem Cell Activator, a groundbreaking supplement that harnesses ...
Prognosis is extremely poor for patients with head and neck squamous cell carcinoma (HNSCC), which accounts for around 90% of all head and neck cancer. Especially in the more aggressive subtype of ...
Researchers create a magnetic nanoscale system that reversibly switches groove and ridge structures to regulate stem cell adhesion and differentiation. (Nanowerk Spotlight) Tissue regeneration depends ...
Xcellara™ Stem Cell Activator has been scientifically shown to significantly increase circulating stem cells in humans, dogs, horses, and other mammals. Stem cells foster cellular regeneration and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results